Sponsor Pipeline

EyeD Pharma Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
1
Disease Areas
4
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-07-31 NCT07036510
Safety and Efficacy of TimoD Sustained-Release Implant in Participants With Glaucoma or…		 Phase changed: Phase 1 -> Phase 1/2
2026-07-31 NCT07036510
Safety and Efficacy of TimoD Sustained-Release Implant in Participants With Glaucoma or…		 Primary endpoint(s) modified
2026-07-31 NCT07036510
Safety and Efficacy of TimoD Sustained-Release Implant in Participants With Glaucoma or…		 Enrollment increased: 18 -> 42 participants
2026-07-31 NCT07036510
Safety and Efficacy of TimoD Sustained-Release Implant in Participants With Glaucoma or…		 Trial arms changed: 3 -> 4
Active Trials by Phase
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT07036510 Safety and Efficacy of TimoD Sustained-Release Implant in Participants With Glaucoma or… Glaucoma Recruiting
Disease Areas
Hypertension (1)
Get alerts when EyeD Pharma's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free